Suggestions
James Kennedy
President of CDIMD - ICD-10 Physician Champions
Professional Background
Dr. James Kennedy, MD, CCS, is a distinguished medical professional with an impressive career spanning various domains within healthcare and clinical documentation. As a seasoned physician executive, he has attained significant expertise in the realms of clinical documentation improvement and healthcare solutions. His extraordinary dedication and profound understanding of medicine have empowered him to take on leadership roles in prominent organizations across the healthcare sector.
Dr. Kennedy currently serves as the President at CDIMD, where he leverages his comprehensive knowledge to enhance clinical documentation practices and promote excellence within the industry. His leadership at CDIMD reflects his commitment to improving patient care through accurate documentation, ultimately benefiting healthcare providers and patients alike. His previous role as President at VP-MA Health Solutions further underscores his proficiency in healthcare strategies tailored to elevate the quality of clinical outcomes.
Before establishing himself as a leader in clinical documentation, Dr. Kennedy had a robust foundation as an Internal Medicine Physician at the Vanderbilt University Medical Center. His clinical experience has provided him with insightful perspectives on patient management and treatment protocols, contributing to his effectiveness in administrative and consultative roles.
In addition to his roles in executive leadership, Dr. Kennedy has enriched his professional profile by engaging with various esteemed organizations. He has been an active member of the American College of Physicians, advocating for advancement and supportive policies in the medical community. Moreover, his contributions as a former advisory board member at the Association of Clinical Documentation Specialists highlight his commitment to fostering collaboration within the documentation improvement arena.
Dr. Kennedy also held several influential positions within healthcare consulting. As the Managing Director at FTI Consulting and Senior Physician Executive at Cambio Health Solutions, he worked diligently to implement innovative strategies that enhance healthcare delivery systems. His experiences as a consultant at HMA provided him with vital insights into healthcare operations, making significant contributions to both patient care and organizational efficiency.
With an extensive background in healthcare and clinical documentation, Dr. Kennedy possesses a diverse skill set that bridges clinical practice with policy development and organizational improvement.
Education and Achievements
Dr. Kennedy's academic journey is characterized by a strong foundation in the sciences and a commitment to medical excellence. He began his educational pursuits at the University of Tennessee-Knoxville, where he earned a Bachelor of Arts in Chemistry. This early focus on the chemical sciences laid the groundwork for his subsequent medical education.
Continuing on his academic path, Dr. Kennedy attended the prestigious University of Tennessee-Health Science Center College of Medicine, where he completed his studies in Medicine and Surgery. This rigorous program equipped him with the necessary skills and knowledge to practice medicine and serve patients with compassion and expertise.
Dr. Kennedy's educational background is not only distinguished by his degrees but also by his commitment to lifelong learning and professional development. His certification as a Certified Coding Specialist (CCS) further exemplifies his dedication to staying at the forefront of advancements in clinical documentation and coding practices.
Achievements
Throughout his career, Dr. Kennedy has made notable contributions to the healthcare field, specifically in clinical documentation, physician leadership, and medical consulting. His leadership roles in organizations focused on clinical documentation improvement and healthcare solutions speak volumes about his talents and the trust placed in him by his peers. His effective strategies and innovative solutions have been instrumental in promoting better healthcare practices.
Dr. Kennedy’s contributions as a contracted author for the American Health Information Management Association (AHIMA) illustrate his commitment to knowledge sharing and educational outreach within the healthcare community. By disseminating best practices in clinical documentation, he has helped empower healthcare professionals in their pursuit of accuracy and compliance in medical documentation.
In summary, Dr. James Kennedy stands out as a leading figure in the healthcare industry, celebrated for his clinical acumen, leadership abilities, and dedication to improving patient outcomes through enhanced clinical documentation.
title
James Kennedy's extraordinary journey in medicine has seen him make lasting contributions!
Highlights
Critical Update: Hypertensive (HTN) Emergency On October 1, 2024, the CDC implements the "Use Additional Code" instruction for I16.1, HTN Emergency whereby linkage of any condition (e.g., decompensated heart failure, stroke, HTN encephalopathy) occasioning an inpatient admission to HTN emergency requires I16.1 be the principal diagnosis, not the linked condition (e.g., heart failure). Reference: https://lnkd.in/gV5g9ki3
This instruction does NOT apply to I16.9, HTN crisis (a CC with MS-DRGs) or I16.0, HTN urgency (not a MS-DRG CC), only to I16.1, HTN emergency (a MS-DRG CC).
Why? Coders must follow the ICD-10-CM Etiology/Manifestation conventions (FY2025 Guidelines pages 10-11 - https://lnkd.in/givc7SUA) that state:
"ICD-10-CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology (e.g., I16.1, HTN emergency) followed by manifestation (e.g., hemorrhagic stroke)."
Dr. Kennedy recommends:
- Master HTN crisis/urgency/emergency definitions HTN crisis (MS-DRG CC) = systolic BP >180 mm Hg OR diastolic BP >120 mm Hg. Easy as that. It's "OR", not "AND". HTN urgency (Not a MS-DRG CC) = HTN crisis WITHOUT end-organ involvement (e.g., cardiac, renal, and neurologic injury) that may generally be treated w/oral antihypertensives as an outpatient HTN emergency (MS-DRG CC) = HTN crisis RESULTING IN acute end-organ damage warranting intensive care for immediate BP reduction with short-acting titratable IV antihypertensive medications. Reference: https://lnkd.in/ghvkqiFR.
- Avoid terms like "malignant HTN", "uncontrolled HTN" (when HTN crisis criteria is met), and others; these code to unspecified HTN (ICD-10-CM code I10) that commonly do not affect risk adjustments
- Avoid defaulting only to "HTN crisis" when HTN emergency (because of sequencing) or urgency (as to gain a CC) truly exist. Willful neglect or reckless disregard to failing to obtain HTN emergency or urgency when present as to increase one's reimbursement with I16.9, HTN crisis = fraud. Reference: False Claims Act - https://lnkd.in/gKJ2dpDW
- Since every admission for HTN encephalopathy involves HTN emergency, there should be absolutely no MS-DRG 77-79, Hypertensive Encephalopathy, assignments (https://lnkd.in/gfkjGqDP) since I16.1 should be the PDx. These will group to MS-DRG 304-305 where a CC adds no weight. https://lnkd.in/gpY8V5tT
Sadly, this sequencing rule reduces reimbursements, move these admits to MDC 5 (CV, with I16.1 as the PDx) instead of others, e.g., MDC 1 (Neurology), and creates compliance risks if ICD-10-CM conventions are not followed.
Please repost and comment as to what you will do where you work.
Most everyone is frustrated with AHRQ's PSI 4 which contributes 2.5% to one's Leapfrog Safety Grade and to CMS's Inpatient Quality Reporting score, given this PSI measures surgical patient survival in the setting of various strata (e.g., shock (including cardiac arrest), sepsis, pneumonia, GI bleed, and DVT/PE), not the occurrence of PSI-triggering events (e.g., postop respiratory failure, etc.). https://lnkd.in/ewh6CdF6
Here's some good news; CMS feels your pain and is doing something about it.
As announced in the FY2025 IPPS Proposed Rule (https://lnkd.in/ebqqC3Gv), they propose to substitute PSI 04 with the Thirty-day Risk-Standardized Death Rate Among Surgical Inpatients with Complications (Failure-to-Rescue) Measure (FTR Measure) beginning with their FY 2027 Payment, whose methodology is available at https://lnkd.in/eUMHfCAA.
Challenges to the PSI-04 methodology in the past included:
• Complications sometimes develop before the index operation in CMS PSI 04, even before transferring to the index hospital. For example, the operation is part of an effort to “rescue” the patient. • The heterogeneous cohort includes patients with very high-risk surgery (for example, trauma or burn surgery, organ transplants, intracranial hemorrhage) and very low-risk surgery (for example, eye, ear, urolithiasis). • Mean length of stay and prevalence of early discharge to post-acute facilities vary across hospitals, causing bias in comparing performance. CMS PSI 04 may slightly disadvantage teaching hospitals, even after risk-adjustment, due to residual confounding from unmeasured case-mix differences.
As such, CMS cites the following differences between PSI 04 and their new FTR methodology which will:
- Capture all deaths of denominator-eligible patients within 30 days of the first qualifying operating room procedure, regardless of site.
- Limit the denominator to patients in general surgical, vascular, and orthopedic MS-DRGs.
- Exclude patients whose relevant complications preceded (rather than followed) their first inpatient operating room procedure, while broadening the definition of denominator-triggering complications to include other complications that may predispose to death (e.g., pyelonephritis, osteomyelitis, acute MI, stroke, acute renal failure, heart failure/volume overload).
- Include Medicare Advantage patients whereas PSI 04 and other PSIs only included the traditional Medicare population.
Please contact your facility’s quality management to learn more about this new model and its inclusions, exclusions, and especially its risk-adjustment (which involves the Elixhauser model). Strong CDI-infused perioperative evaluations mitigate facility risk with all PSIs and CMS's new FTR models. Chat with me or my friend, Solomon Aronson, MD, of PeriOptions to process how to implement proactive CDI principles affecting all models (e.g., DRGs, HCCs, Elixhauser), including these.
